Stellar Expansion Predicted for Global Microbiome Sequencing Services Market as New Drug (IND) Requirements for Fecal Microbiota and Technological Innovations Offer Immense Opportunities
July 17, 2023 05:28 ET
|
Research and Markets
Dublin, July 17, 2023 (GLOBE NEWSWIRE) -- The "Global Microbiome Sequencing Services Market (2023-2028) by Technology, Laboratory, Research, Products & Services, Application, End-User, Geography...
EnteroBiotix appoints Elmar Schnee as Executive Chairman
July 17, 2023 03:00 ET
|
EnteroBiotix
GLASGOW, Scotland, July 17, 2023 (GLOBE NEWSWIRE) -- EnteroBiotix Limited (“EBX”), a clinical stage company with the premier platform for full-spectrum microbiome therapeutics, today announced the...
Axial Therapeutics Receives Second Research Grant Award from The Michael J. Fox Foundation to Further Support Advancement of AX-5006 for Parkinson’s Disease
June 20, 2023 08:00 ET
|
Axial Therapeutics
–Grant supports the continued preclinical development of AX-5006, a small molecule, gut-restricted amyloid inhibitor for symptomatic treatment and modification of disease in PD– –IND-enabling...
Human Microbiome market is projected to grow at a CAGR of 25.0% by 2033: Visiongain
June 16, 2023 07:24 ET
|
Visiongain Reports Ltd
As per the report by Visiongain, the Human Microbiome Market was valued at US$186.8 million in 2022 and is projected to grow at a CAGR of 25.0 % during the forecast period 2023-2033. Visiongain has...
Global Human Microbiome Market Analysis Report 2023-2033: Big Pharma Players Striving To Gain Market Entry Through Collaboration with Microbiome Players
June 12, 2023 04:48 ET
|
Research and Markets
Dublin, June 12, 2023 (GLOBE NEWSWIRE) -- The "Human Microbiome Market Report 2023-2033" report has been added to ResearchAndMarkets.com's offering.Overall world revenue will surpass US$224 million...
Global Microbiome Partnering Terms and Agreements Report 2023: Look at Top Deals by Value
June 09, 2023 08:03 ET
|
Research and Markets
Dublin, June 09, 2023 (GLOBE NEWSWIRE) -- The "Global Microbiome Partnering Terms and Agreements 2010 to 2023" report has been added to ResearchAndMarkets.com's offering.This report provides an...
Finch Announces Reverse Stock Split of Common Stock
June 09, 2023 07:00 ET
|
Finch Therapeutics Group, Inc.
BOSTON, June 09, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio of...
Global Human Microbiome Market Report to 2029: Rising Awareness About Importance of Human Microbiome Drives Growth
June 06, 2023 09:53 ET
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Human Microbiome Market by Product (Drugs, Probiotics, Prebiotics), Application (Therapeutic, Diagnostics), Disease (Cancer, Gastrointestinal,...
Global Microbiome Sequencing Services Market Report 2023: Increasing Demand for Metagenomic Sequencing Drives Growth
May 29, 2023 07:53 ET
|
Research and Markets
Dublin, May 29, 2023 (GLOBE NEWSWIRE) -- The "Global Microbiome Sequencing Services Market by Service (Sample Preparation, Sequencing, Library Preparation), Type (Amplicon Sequencing, Whole Genome...
Finch Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Updates
May 10, 2023 07:00 ET
|
Finch Therapeutics Group, Inc.
SOMERVILLE, Mass., May 10, 2023 (GLOBE NEWSWIRE) -- Finch Therapeutics Group, Inc. (“Finch”, “Finch Therapeutics” or the “Company”) (Nasdaq: FNCH), a microbiome technology company with a portfolio...